Upload File

Download - K062511 -- 510 K Alveolus Inc

Transcript

  • 8/14/2019 K062511 -- 510 K Alveolus Inc.

    1/5

  • 8/14/2019 K062511 -- 510 K Alveolus Inc.

    2/5

  • 8/14/2019 K062511 -- 510 K Alveolus Inc.

    3/5

  • 8/14/2019 K062511 -- 510 K Alveolus Inc.

    4/5

  • 8/14/2019 K062511 -- 510 K Alveolus Inc.

    5/5


Top Related

510(k) Summary in accordance with 21 CFR 807.92(c)k) for Lipogems System Page 1 of 5 510(k) Summary in accordance with 21 CFR 807.92(c) Device Name: The Lipogems System Type of 510(k)
510(k) Summary in accordance with 21 CFR 807.92(c)k) for Lipogems System Page 1 of 5 510(k) Summary in accordance with 21 CFR 807.92(c) Device Name: The Lipogems System Type of 510(k)
CDRH, Congress and the 510(k) Process
CDRH, Congress and the 510(k) Process
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION … · 2019. 3. 13. · 1 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY A. 510(k) Number: K183446 B. Purpose
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION … · 2019. 3. 13. · 1 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY A. 510(k) Number: K183446 B. Purpose
Diagnostic/Biomarker Development Breakout...• Abbreviated 510(k): 510(k) guidance/special controls or recognized standard available • De novo 510(k): no substantial equivalent
Diagnostic/Biomarker Development Breakout...• Abbreviated 510(k): 510(k) guidance/special controls or recognized standard available • De novo 510(k): no substantial equivalent
510(k) Summary - Food and Drug AdministrationSonoScape Company Limited 510(k) Submission 510(k) Summary This summary of 510(k) safety and effectiveness information is being submitted
510(k) Summary - Food and Drug AdministrationSonoScape Company Limited 510(k) Submission 510(k) Summary This summary of 510(k) safety and effectiveness information is being submitted
The 510(k) Program: Evaluating Substantial Equivalence … · The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)] Guidance for Industry and
The 510(k) Program: Evaluating Substantial Equivalence … · The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)] Guidance for Industry and
Invader®O MTHFR 677 510(k) SUMMARY MAY 13 2011 · 2011-06-27 · Invader®O MTHFR 677 510(k) SUMMARY MAY 13 2011 A. 510(k) Number: K 100987 B. Purpose for Submission: New Device
Invader®O MTHFR 677 510(k) SUMMARY MAY 13 2011 · 2011-06-27 · Invader®O MTHFR 677 510(k) SUMMARY MAY 13 2011 A. 510(k) Number: K 100987 B. Purpose for Submission: New Device
POC Section III: Summary Section III: 510(k) Summary · *Roche Diagnrostics cobas® b 123 POC System Section III: 510(k) Summary Section III: 510(k) Summary $ (/ 510(k) Summary MAY
POC Section III: Summary Section III: 510(k) Summary · *Roche Diagnrostics cobas® b 123 POC System Section III: 510(k) Summary Section III: 510(k) Summary $ (/ 510(k) Summary MAY